Veno-venous Extracorporeal Membrane Oxygenation Support in COVID-19 Respiratory Distress Syndrome: Initial Experience
Antonio Loforte, Erika Dal Checco, Gregorio Gliozzi, Maria Benedetto, Giulio Giovanni Cavalli, Carlo Mariani, Giulia Piccone, Marta Agulli, Davide Pacini, Massimo Baiocchi
Abstract
SARS-CoV-2 may cause severe respiratory failure due to massive alveolar damage. Currently, no adequate curative therapy for Coronavirus Disease 2019 (COVID-19) disease exists. By considering overall impact of COVID-19 pandemic outbreak, an increased need of extracorporeal membrane oxygenation (ECMO) support becomes evident. We report on our preliminary institutional experience with COVID-19 patients receiving venovenous ECMO support.
Topics & Concepts
Extracorporeal membrane oxygenationCoronavirus disease 2019 (COVID-19)MedicineIntensive care medicineRespiratory failureSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pandemic2019-20 coronavirus outbreakARDSOutbreakDiseaseAcute respiratory distressRespiratory distressOxygenationAnesthesiaLungInternal medicineVirologyInfectious disease (medical specialty)Mechanical Circulatory Support DevicesSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies